Coronavirus Outbreak: ‘Potential drug target against COVID-19 infection identified’

By: |
Updated: Mar 06, 2020 11:03 AM

The new coronavirus, SARS-CoV-2, has spread worldwide, causing respiratory disease called COVID-19 in people -- leading to over 3,000 deaths, and infecting more than 90,000 individuals.

Coronavirus, Coronavirus India, coronavirus risk in India, chances of coronavirus spreading to India, study on coronavirus risk, Coronavirus latest updates, Coronavirus outbreak, n95 mask, wuhan university, sars, nipah virus, n95 respirator mask, kerala virus, karona, carona, Coronavirus symptoms, Coronavirus treatment, Coronavirus medicine, Coronavirus prevention, coronavirus treatment breakthrough, coronavirus treatment, coronavirus medicine, coronavirus treatment foundCurrently no vaccines or drugs are available to combat these viruses.

Researchers have identified a protein present in the human body which they claim is important for the entry of the novel coronavirus into lung cells, an advance that may lead to a novel drug target for preventing the deadly disease.

Catch live updates on coronavirus here

The researchers, including those from Deutsches Primatenzentrum in Germany, said the new coronavirus, SARS-CoV-2, has spread worldwide, causing respiratory disease called COVID-19 in people — leading to over 3,000 deaths, and infecting more than 90,000 individuals.

According to the study, published in the journal Cell, the virus has been spreading since December 2019, and is closely related to the SARS coronavirus that caused the Severe Acute Respiratory Syndrome pandemic in 2002-2003.

It noted that currently no vaccines or drugs are available to combat these viruses.

The scientists sought to find out how the new coronavirus entered host cells, and how this process can be blocked.

They identified a cellular protein that is important for the entry of the novel coronavirus into lung cells.

“Our results show that SARS-CoV-2 requires the protease TMPRSS2, which is present in the human body, to enter cells,” said Stefan Pohlmann, study co-author from the German Primate Center.

“This protease is a potential target for therapeutic intervention,” Pohlmann said.

The researchers said a drug camostat mesilate — approved in Japan for use in pancreatic inflammation — is known to inhibit the protease TMPRSS2.

They investigated whether this drug can also prevent COVID-19.

“We have tested SARS-CoV-2 isolated from a patient and found that camostat mesilate blocks entry of the virus into lung cells,” said Markus Hoffmann, another co-author of the study.

“Our results suggest that camostat mesilate might also protect against COVID-19. This should be investigated in clinical trials,” Hoffmann said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Tata group to launch India’s first CRISPR COVID-19 test
2COVID-19 in Karnataka: Total recoveries breach 4-lakh mark; 8,364 new cases
3COVID-19: China eases restrictions on theatres, entertainment venues